Catherine Hollingsworth

Cortex Slashing Half its Staff in Latest Round of Belt-Tightening

March 20, 2009

Cortex Pharmaceuticals Inc. is cutting about half its staff, slashing executive salaries and putting some research projects on the back burner, all in an effort to stay afloat in the troubled economy. (BioWorld Today)

NewCo News: Auspex Focuses on Metabolism to Get More Bang from Drugs

March 19, 2009

By Catherine Hollingsworth

Sangart Completes $50M Series F for MP4 Molecule

March 13, 2009

By Catherine Hollingsworth

NewCo News: Dynamix Finds Right Fit in a Struggling Economy

March 12, 2009

By Catherine Hollingsworth

NewCo News: With Programs and Cash, Avineuro Goes Shopping

March 11, 2009

By Catherine Hollingsworth

Roche, Evotec Collaborating in $300M Depression Drug

March 11, 2009

By Catherine Hollingsworth and Cormac Sheridan

Roche, Evotec Collaborating in $300M Depression Drug

March 10, 2009

By Catherine Hollingsworth and Cormac Sheridan

AEterna Partners with Sanofi in $165M Deal for BPH Drug

March 9, 2009

By Catherine Hollingsworth

Proteon Snares $38M Round, and $550M Novartis Option

March 6, 2009

By Catherine Hollingsworth

Proteon Therapeutics Inc. is banking on its lead product to clear a crucial Phase II study, the results of which could seal a $550 million deal with Novartis AG. (BioWorld Today)